ResMed Inc (RMD) News

Citigroup Adjusts Price Target on ResMed to $270 From $340, Maintains Buy Rating

MT Newswires17:18 · Ratings

Weekly Top Ten News Stories – 12 June 2026

FNArenaJun 12 08:45

ResMed CEO Farrell Exercises Options and Sells Shares Under 10b5-1 Plan

TipRanksJun 10 07:05

Resmed Insider Sold Shares Worth $968,064, According to a Recent SEC Filing

MT NewswiresJun 10 02:40

Ord Minnett Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)

TipRanksJun 4 11:06 · Ratings

ResMed General Counsel Trims Holdings to Cover RSU Tax Liability

TipRanksJun 4 07:12

Express News | Resmed Inc-Statement of Changes in Beneficial Ownership

BreakingsJun 4 06:21

Express News | Angelini Ventures Marks First Portfolio Company Exit as Resmed Acquires Noctrix Health for $340 Million

BreakingsJun 3 19:41

ResMed Completes Acquisition of Noctrix Health

MT NewswiresJun 2 06:47

Wells Fargo Keeps Their Hold Rating on Resmed (RMD)

TipRanksJun 1 09:21 · Ratings

ResMed Files 2025 Conflict Minerals Disclosure Under SEC Rules

TipRanksMay 27 06:57

ResMed Inc: Form SD

ASXMay 27 06:25 · Announcements

Analysts Are Bullish on Top Healthcare Stocks: EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (AU:EBR), West Pharmaceutical Services (WST)

TipRanksMay 21 17:01 · Ratings

ResMed Rises After Partnership With Oura to Expand Sleep Health Education, Care Pathways

MT NewswiresMay 20 08:52

Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference

GlobeNewswireMay 20 04:05

ResMed Targets Circadian Data With New Wearable Trial: What Investors Should Watch

TipRanksMay 20 00:30

Express News | Resmed and Ōura Partner to Expand Access to Sleep Health Education and Care

BreakingsMay 19 21:00

Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care

GlobeNewswireMay 19 21:00

Analyst Maintains Hold on ResMed as Noctrix Acquisition Offers Limited Incremental Growth Amid Competitive Risks

TipRanksMay 15 16:35 · Ratings

Macquarie Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)

TipRanksMay 14 08:07 · Ratings